BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28303447)

  • 1. Editorial: Cutting edge in systemic lupus erythematosus.
    D'Cruz DP; Kuhn A
    Immunol Res; 2017 Apr; 65(2):429-431. PubMed ID: 28303447
    [No Abstract]   [Full Text] [Related]  

  • 2. When to use belimumab in SLE.
    Gatto M; Iaccarino L; Zen M; Doria A
    Expert Rev Clin Immunol; 2017 Aug; 13(8):737-740. PubMed ID: 28463023
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcutaneous belimumab in the treatment of systemic lupus erythematosus.
    Elalouf O; Keeling SO; Touma Z
    Immunotherapy; 2018 Sep; 10(13):1163-1173. PubMed ID: 30105936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Belimumab--the biological drug for systemic lupus erythematosus: as discussed during the American College of Rheumatology (ACR) conference - 2012].
    Vadasz Z; Toubi E
    Harefuah; 2013 May; 152(5):304-6. PubMed ID: 23885457
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic Lupus Erythematosus and Antiphospholipid Syndrome-The Double Trouble.
    Londhey V
    J Assoc Physicians India; 2017 Mar; 65(3):11-12. PubMed ID: 28462537
    [No Abstract]   [Full Text] [Related]  

  • 6. Subcutaneous and intravenous belimumab in the treatment of systemic lupus erythematosus: a review of data on subcutaneous and intravenous administration.
    Poh YJ; Baptista B; D'Cruz DP
    Expert Rev Clin Immunol; 2017 Oct; 13(10):925-938. PubMed ID: 28847197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Belimumab for the treatment of systemic lupus erythematosus.
    Jordan N; D'Cruz DP
    Expert Rev Clin Immunol; 2015 Feb; 11(2):195-204. PubMed ID: 25543845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic lupus erythematosus - Standards in 2015].
    Aringer M; Schneider M
    Dtsch Med Wochenschr; 2014 Sep; 139(37):1813-6. PubMed ID: 25180995
    [No Abstract]   [Full Text] [Related]  

  • 9. Belimumab: a guide to its use in systemic lupus erythematosus.
    Scott LJ; Burness CB; McCormack PL
    BioDrugs; 2012 Jun; 26(3):195-9. PubMed ID: 22428610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of rivaroxaban in patients with antiphospholipid syndrome: A series of 12 cases.
    Son M; Wypasek E; Celinska-Lowenhoff M; Undas A
    Thromb Res; 2015 May; 135(5):1035-6. PubMed ID: 25669601
    [No Abstract]   [Full Text] [Related]  

  • 11. [Autoimmune habitual abortion].
    Nouza K; Madar J; Kinský R; Dostál C; Palecková A
    Ceska Gynekol; 1996 Oct; 61(5):310-6. PubMed ID: 9004981
    [No Abstract]   [Full Text] [Related]  

  • 12. [Systemic lupus erythematosus. Anti-phospholipid syndrome].
    Fain O
    Rev Prat; 2008 Nov; 58(17):1935-42. PubMed ID: 19157212
    [No Abstract]   [Full Text] [Related]  

  • 13. [IL-2-Therapy in SLE- Selective reconstitution of immunological tolerance].
    Humrich JY; Riemekasten G
    Z Rheumatol; 2016 Jun; 75(5):490-2. PubMed ID: 27250490
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticardiolipin syndrome, aspirin therapy and fetal malformation.
    Chakravarty K; Merry P
    Lupus; 1993 Feb; 2(1):61-2. PubMed ID: 8485562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal antiphospholipid syndrome presenting as neonatal lupus with congenital complete heart block in the fetus.
    Abu-Ras R; Felser K; Rottem M
    Isr Med Assoc J; 2001 Dec; 3(12):966-8. PubMed ID: 11794929
    [No Abstract]   [Full Text] [Related]  

  • 16. Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment.
    de Amorim LC; Maia FM; Rodrigues CE
    Lupus; 2017 Apr; 26(5):529-536. PubMed ID: 28394226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of Clinical Trials of Belimumab in the Management of Systemic Lupus Erythematosus.
    Garcia A; De Sanctis JB
    Curr Pharm Des; 2016; 22(41):6306-6312. PubMed ID: 27587201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C4 deficiency state in antiphospholipid antibody-related recurrent preeclampsia evolving into systemic lupus erythematosus.
    Queiro R; Weruaga A; Riestra JL
    Rheumatol Int; 2002 Jul; 22(3):126-8. PubMed ID: 12111090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asplenia in a patient with systemic lupus erythematosus and antiphospholipid antibodies.
    Pettersson T; Julkunen H
    J Rheumatol; 1992 Jul; 19(7):1159. PubMed ID: 1512781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.